-
If you purchased shares of Revance Therapeutics Inc (NASDAQ: RVNC), you might have certain options and should contact the Shareholders Foundation, Inc.
-
To have your information reviewed for options and to receive notifications about this case, please send an email to mail@shareholdersfoundation.com, or call us at (858) 779-1554.
Lawsuit Overview
The settlement includes all persons and entities that purchased or otherwise acquired Revance Therapeutics Inc (NASDAQ: RVNC) common stock during June 19, 2014 and May 1, 2015, and pursuant and/or traceable to the Registration Statement and prospectus for the company's June 19, 2014 Public Offering. August 1, 2017 - The court approved the settlement. January 6, 2017 - The court pr...
You must register (for free) or login to view the entire case.
